Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests
Angelo Ghezzi, N. Canal(University of Milan), Vittorio Martinelli(Vita-Salute San Raffaele University), Gıancarlo Comı(Casa di Cura Columbus), A. Zibetti(Associazione Italiana Sclerosi Multipla), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), M. Rodegher(Vita-Salute San Raffaele University), Valter Torri(Istituti di Ricovero e Cura a Carattere Scientifico)
Cited by 106
Related Papers
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study
|The Lancet|2001|1.1k
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
|The Lancet Oncology|2016|1k
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706